Literature DB >> 681999

Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients.

D Cerrato, C Ariano, F Fiacchino.   

Abstract

By the use of 125I-labeled fibrinogen test, the incidence of postoperative deep vein thrombosis (DVT) and the effectiveness of prophylactic low-dose heparin treatment were investigated in 110 patients who underwent elective neurosurgical procedures. Fifty patients were appointed randomly to a control group and 50 to a heparin group (10 patients were excluded since they had DVT before surgery). The incidence of DVT was reduced from 34% in the control group to 6% in the heparin group (p less than 0.005). No statistically significant differences were observed in transfusion requirements, postoperative hemoglobin concentration, and the occurrence of postoperative hematomas between the two groups. Positive correlation was observed between DVT and motor deficit (p less than 0.05). Preoperative assessment of patients' sensitivity to the standard 5000-unit dose of heparin was performed in all treated patients and is thought an important factor in improving the safety of heparin prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681999     DOI: 10.3171/jns.1978.49.3.0378

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  36 in total

1.  Post-operative thromboembolism in neurosurgery. A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin.

Authors:  S Boström; E Holmgren; O Jonsson; S Lindberg; B Lindström; I Winsö; B Zachrisson
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

2.  Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period.

Authors:  Timothy R Smith; Rishi R Lall; Randall B Graham; Jamal Mcclendon; Rohan R Lall; Allan D Nanney; Joseph G Adel; Anaadriana Zakarija; James P Chandler
Journal:  J Neurooncol       Date:  2014-07-26       Impact factor: 4.130

3.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

4.  Controversies in the medical management of stroke.

Authors: 
Journal:  West J Med       Date:  1985-01

5.  Suprasellar and olfactory meningiomas. Report on a series of 153 personal cases.

Authors:  C L Solero; S Giombini; G Morello
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

6.  Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations.

Authors:  U F Gruber; J Rem; C Meisner; O Gratzl
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

Review 7.  Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology.

Authors:  Marc Carrier; Agnes Y Y Lee
Journal:  Nat Clin Pract Oncol       Date:  2008-10-28

8.  Deep vein thrombosis after aneurysm surgery.

Authors:  A Tapaninaho
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

9.  Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile.

Authors:  R Sawaya; M Zuccarello; M Elkalliny; H Nishiyama
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

10.  Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.

Authors:  D Voth; M Schwarz; K Hahn; K Dei-Anang; S al Butmeh; H Wolf
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.